SCHEMBL1703121

SCHEMBL1703121

O=C(CCl)NC(=O)Nc1ccccc1-c1nc2ccccc2c(=O)o1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 6/20 0.53
▸ MEN1 O00255 5/20 0.53
▸ C1R P00736 7/20 0.52
▸ ALDH1A1 P00352 6/20 0.51
▸ MAPT P10636 3/20 0.51
▸ F2 P00734 2/20 0.49
▸ PLG P00747 1/20 0.49
▸ KLK1 P06870 1/20 0.49
▸ PRSS1 P07477 1/20 0.49
▸ C1S P09871 1/20 0.49
▸ ATM Q13315 1/20 0.49
▸ L3MBTL1 Q9Y468 1/20 0.49
▸ GAA P10253 3/20 0.48
▸ KDM4E B2RXH2 3/20 0.48
▸ LMNA P02545 1/20 0.47
▸ CYP1A2 P05177 2/20 0.46
▸ CYP3A4 P08684 2/20 0.46
▸ CYP2C19 P33261 2/20 0.46
▸ USP2 O75604 1/20 0.46
▸ TP53 P04637 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14560092 0.83 C1R (0.66) KMT2AMEN1C1RALDH1A1MAPT
SCHEMBL14560103 0.82 ALDH1A1 (0.59) KMT2AMEN1C1RALDH1A1MAPT
SCHEMBL3810516 0.82 KMT2A (0.58) KMT2AMEN1C1RALDH1A1MAPT
SCHEMBL14560080 0.81 KMT2A (0.57) KMT2AMEN1C1RALDH1A1MAPT
SCHEMBL3710461 0.81 ATM (0.62) KMT2AMEN1C1RALDH1A1MAPT
Hydrochloric Acid SCHEMBL10923922 0.81 KMT2A (0.56) KMT2AMEN1C1RALDH1A1MAPT
SCHEMBL14560084 0.81 KMT2A (0.56) KMT2AMEN1C1RALDH1A1MAPT
SCHEMBL14560091 0.80 ALDH1A1 (0.62) KMT2AMEN1C1RALDH1A1MAPT
SCHEMBL7190207 0.80 KMT2A (0.61) KMT2AMEN1C1RALDH1A1MAPT
SCHEMBL7193497 0.79 KMT2A (0.62) KMT2AMEN1C1RALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2195395-B1 NEW ORGANIC FLUORESCENT SULFONYL UREIDO BENZOXAZINONE PIGMENTS HONEYWELL INT INC (US) 2012-04-18 — — EP disclosed
CN-101809099-A Novel organic fluorescent sulfonylureido benzo-oxazinone pigments HONEYWELL INT INC 2010-08-18 — — CN disclosed
US-7740693-B2 E.g., 1-(p-toluenesulfonyl)-3-[2-(4-oxo-4H-benzo[d]-[3.1]oxazine-2-yl)-phenyl]urea; fluorine-free; marking currency, passports, chip cards, checks, check cards, credit cards, debit cards, identity cards, certificates, bank notes, and postal items HONEYWELL INTERNATIONAL INC. 2010-06-22 — — US disclosed
EP-2195395-A2 NEW ORGANIC FLUORESCENT SULFONYL UREIDO BENZOXAZINONE PIGMENTS Honeywell International Inc. (US) 2010-06-16 — — EP disclosed
WO-2009045988-A2 NEW ORGANIC FLUORESCENT SULFONYL UREIDO BENZOXAZINONE PIGMENTS HONEYWELL INTERNATIONAL INC. (US) 2009-04-09 — — WO disclosed
US-20090085344-A1 E.g., 1-(p-toluenesulfonyl)-3-[2-(4-oxo-4H-benzo[d]-[3.1]oxazine-2-yl)-phenyl]urea; fluorine-free; marking currency, passports, chip cards, checks, check cards, credit cards, debit cards, identity cards, certificates, bank notes, and postal items HONEYWELL INTERNATIONAL INC. 2009-04-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090085344-A1 E.g., 1-(p-toluenesulfonyl)-3-[2-(4-oxo-4H-benzo[d]-[3.1]oxazine-2-yl)-phenyl]urea; fluorine-free; marking currency, passports, chip cards, checks, check cards, credit cards, debit cards, identity cards, certificates, bank notes, and postal items H1-10, KDM4C, H1-4 KMT2A 186/4885MEN1 4505/4885C1R 4579/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback